自噬
PI3K/AKT/mTOR通路
诱导剂
化学
载脂蛋白B
内科学
蛋白激酶B
载脂蛋白E
药理学
癌症研究
胆固醇
细胞凋亡
细胞生物学
生物化学
医学
信号转导
生物
基因
疾病
作者
Qingping Xiong,Zhuan Yan,Jian Liang,Jun Yuan,Xueling Chen,Li Zhou,Youdong Hu,Jun Wu,Yi Jing,Qianghua Zhang,Hailun Li,Yingying Shi
出处
期刊:Phytomedicine
[Elsevier]
日期:2020-11-23
卷期号:81: 153301-153301
被引量:15
标识
DOI:10.1016/j.phymed.2020.153301
摘要
Polydatin has been reported to possess remarkable anti-atherosclerotic activities. However, there are different opinions on its regulatory mechanisms. It remains unclear whether the anti-atherosclerotic mechanism of polydatin is related to its autophagic restoration or not. The aim of this study was to explore the question. Using atherosclerotic model induced by high-fat diet in apolipoprotein E-deficient mice, the investigation was performed with polydatin alone or in combination with autophagic inhibitor or inducer intervention. Inhibitory sites of polydatin to PI3K were identified by molecular docking. Polydatin can significantly inhibit PI3K/Akt/mTOR pathway proteins expression, improve autophagic dysfunction and reduce atherosclerotic lesions. These effects could be antagonized and reinforced by adding autophagic inhibitor and inducer, respectively. Inhibitory sites of polydatin to PI3K were found to be ASP-810, SER-854, VAL-851, LEU-807, SER-774, LYS-802, ASP-933, SER-919, ASN-920, PHE-930, MEF-922, GLN-859 of PI3Kα. The mechanism of polydatin to alleviate atherosclerotic lesions was achieved by autophagic restoration.
科研通智能强力驱动
Strongly Powered by AbleSci AI